BioCentury

8:00 AM GMT, Feb 21, 2011
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical Status

Syncria albiglutide: Completed Phase III enrollment

GlaxoSmithKline disclosed in its 4Q10 earnings that it completed enrollment of about

Read the full 121 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.